In summary, the high expression of SIRT7 indicates poor prognosis in breast cancer-luminal, as well as increased immune infiltration levels of M1 macrophages and T cell exhaustion, suggesting that SIRT7 may serve as a prognostic biomarker associated with immune infiltration in breast cancer-luminal. This evidence concerns the gene SIRT7 and breast cancer.